EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis

Laura Parisio, Giuseppe Cuccia iD, Anna Giudice, Federico Carrabetta iD, Angelo Del Gaudio, Giuseppe Privitera, Luigi Carbone iD, Rocco Spagnuolo iD, Daniela Pugliese

Journal of Clinical Medicine · 28.06.2025 · 14 (13) · 4590

DOI: 10.3390/jcm14134590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.06.2025. Verfasst von Laura Parisio und 8 weiteren Autor:innen. Beteiligte Einrichtung: UOS Gastroenterologia, Ospedale Isola Tiberina Gemelli Isola, 00186 Rome, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-23 (IL-23) is a key cytokine involved in the pathogenesis of various immuno-mediated inflammatory diseases. In recent years, several drugs selectively targeting IL-23 have been developed and three of them (mirikizumab, risankizumab and guselkumab) were successfully investigated in clinical trials for ulcerative colitis (UC). All of them showed a good profile for efficacy, alleviating symptoms, and inducing endoscopic and histologic improvement, with very low incidence of adverse events. Bowel urgency also emerged as a crucial outcome from patients’ perspective in the mirikizumab trials. The correct positioning of IL-23 inhibitors in the therapeutic algorithm for UC represents a new challenge for physicians, especially because it is not guided by biomarkers or predictors of effectiveness. Moreover, no comparative clinical data exist among the available IL-23 inhibitors, although molecular differences might potentially impact their effectiveness. A role for IL-23-inhibitors may also lie in combination with drugs with different mechanisms of action for complex, multi-refractory patients. This review, focusing on UC, summarizes all the clinical data available on IL-23 inhibitors and provides a perspective on the best clinical scenarios to maximize their effectiveness.

Schlagwörter

Stichwörter der Autor:innen

Th17 lymphocytesinterleukin-23monoclonal antibodiesulcerative colitis

Autor:innen und Institutionen

  • UOS Gastroenterologia, Ospedale Isola Tiberina Gemelli Isola, 00186 Rome, Italy.
  • Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Health Sciences Department, Magna Graecia University, 88100 Catanzaro, Italy.
  • Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
  • UOC Pronto Soccorso, Medicina d'Urgenza e Medicina Interna, Ospedale Isola Tiberina Gemelli Isola, 00186 Rome, Italy.
  • IBD UNIT-CEMAD (Centro Malattie Apparato Digerente), Medicina Interna e Gastroenterologia, Fondazione Policlinico A. Gemelli IRCCS, 00168 Rome, Italy.

ORCID-Profile: Giuseppe Cuccia, Federico Carrabetta, Luigi Carbone, Rocco Spagnuolo

Zitieren

APA

Parisio, L., Cuccia, G., Giudice, A., Carrabetta, F., Del Gaudio, A., Privitera, G., Carbone, L., Spagnuolo, R., & Pugliese, D. (2025). Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis. Journal of Clinical Medicine, 14(13), 4590. https://doi.org/10.3390/jcm14134590

Vancouver

Parisio L, Cuccia G, Giudice A, Carrabetta F, Del Gaudio A, Privitera G, et al. Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis. Journal of Clinical Medicine. 2025;14(13):4590. doi:10.3390/jcm14134590

BibTeX
@article{Parisio2025,
  author = {Parisio, Laura and Cuccia, Giuseppe and Giudice, Anna and Carrabetta, Federico and Del Gaudio, Angelo and Privitera, Giuseppe and Carbone, Luigi and Spagnuolo, Rocco and Pugliese, Daniela},
  title = {Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {13},
  pages = {4590},
  doi = {10.3390/jcm14134590}
}
Kostenlos starten →